Arkolith/Insider Trading/NBIO/Form 4

Holden Lowell Thomas

CFO, DirectorNascent Biotech Inc. (NBIO) · full profile →Form 4 · filed Feb 27, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 29, 2023Other(J)120K$0.17$20K9.8M

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001477932-24-000912) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML